According to Westergaard et al. [32] RA patients have high titers of anti-EBNA1 IgM, IgG and IgA antibodies compared to healthy controls and SLE patients, further reinforcing this observed latency profile. This evidence concerns the gene CD79A and rheumatoid arthritis.